Pure Global AI
ANVISA registration 81541770004Valid until Aug 11, 2035

17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING

ANVISA Registration Number: 81541770004SUPER DIAGNOSTICA PRODS HOSP LTDA EPPLABSYSTEMS DIAGNOSTICS OYRisk Class III
Verified
Device names
Technical name
17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING
View exact technical-name matches →
PT: 17-HIDROXIPROGESTERONA (17-OHP) - TRIAGEM NEONATAL
Commercial name
Neonatal 17-OH-Progesterone FEIA
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
81541770004
Process Number
25351038678202572
CNPJ
27437056000164
Company information
Registration Holder
SUPER DIAGNOSTICA PRODS HOSP LTDA EPP
Manufacturer
LABSYSTEMS DIAGNOSTICS OY
Manufacturing Country
Finland
PT: FINLÂNDIA
Dates and status
Publication Date
Aug 11, 2025
Validity
11/08/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for 17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81541770004 and manufactured by LABSYSTEMS DIAGNOSTICS OY. The registration is held by SUPER DIAGNOSTICA PRODS HOSP LTDA EPP with validity until Aug 11, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.